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ABSTRACT: Post-assembly functionalization of supramolecular nanostructures has the potential to expand the range of their
applications. We report here the use of the chemoselective native chemical ligation (NCL) reaction to functionalize self-
assembled peptide amphiphile (PA) nanoﬁbers. This strategy can be used to incorporate speciﬁc bioactivity on the nanoﬁbers,
and as a model, we demonstrate functionalization with the RGDS peptide following self-assembly. Incorporation of bioactivity is
veriﬁed by the observation of characteristic changes in ﬁbroblast morphology following NCL-mediated attachment of the signal
to PA nanoﬁbers. The NCL reaction does not alter the PA nanoﬁber morphology, and biotinylated RGDS peptide was found to
be accessible on the nanoﬁber surface after ligation for binding with streptavidin-conjugated gold nanoparticles. In order to show
that this strategy is not limited to short peptides, we utilized NCL to conjugate yellow ﬂuorescent protein and/or cyan
ﬂuorescent protein to self-assembled PA nanoﬁbers. Förster resonance energy transfer and ﬂuorescence anisotropy
measurements are consistent with the immobilization of the protein on the PA nanoﬁbers. The change in electrophoretic
mobility of the protein upon conjugation with PA molecules conﬁrmed the formation of a covalent linkage. NCL-mediated
attachment of bioactive peptides and proteins to self-assembled PA nanoﬁbers allows the independent control of self-assembly
and bioactivity while retaining the biodegradable peptide structure of the PA molecule and thus can be useful in tailoring design
of biomaterials.
■ INTRODUCTION
A biomaterial developed as an artiﬁcial extracellular matrix
(ECM) mimic must recapitulate several features of the native
ECM. The nanoscale surface features1 and mechanical
properties2 of the scaﬀold should be tuned for the targeted
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tissue in order to achieve precise control of cellular behavior.3
The chemical structure of the biomaterial should ideally contain
chemical bonds that allow biodegradation in vivo and thus
eventually be replaced by native ECM.4 Finally, the method for
incorporating biological functionality into the material should
be applicable to a broad array of bioactive molecules, from
small molecules to peptides to proteins.
Biomaterials based on peptide amphiphiles (PAs) meet many
of these criteria. PA molecules, composed of an oligopeptide
conjugated to a lipid tail, self-assemble into supramolecular
nanostructures.5 The chemical structure of the PA molecule
does not contain any non-natural components or linkages, and
PA nanostructures are biodegradable and biocompatible in
vivo.6 Our group pioneered the use of peptide sequences that
lead to the self-assembly of high aspect ratio cylindrical
nanoﬁbers and at the same time eﬀectively display bioactive
cues on their surfaces.7 This self-assembly process is mediated
by hydrophobic collapse of the lipid tails and β-sheet formation
among oligopeptides.8 The highly entangled PA nanoﬁber gel
mimics the ﬁbrillar nature of native ECM7b and confers tunable
mechanical rigidity and supramolecular cohesiveness.9 Bio-
logical activity is provided by inclusion of bioactive peptide
sequences that can bind soluble ligands or cell surface
receptors.10 The presentation of multiple bioactive cues on a
single PA nanoﬁber at high surface densities11 that maximize
signaling capability can be achieved through coassembly of
diﬀerent PA molecules.12 Through the inclusion of diﬀerent
bioactive cues, PA nanoﬁbers have demonstrated the capacity
to signal for diﬀerentiation,13 proliferation,14 biological
adhesion,15 angiogenesis,16 and insulin secretion.17 Previous
strategies to incorporate bioactivity into PA nanostructures
have generally been limited to short peptide sequences that
allow for the solid-phase peptide synthesis of the entire PA
molecule, including the bioactive sequence. However, the
presence of a bioactive cue can potentially inﬂuence the self-
assembly process of the PA molecules, resulting in the
formation of an altered nanostructure.18 Post-assembly
functionalization of the PA nanostructures with bioactive
groups would allow independent control of self-assembly and
incorporation of bioactivity. Furthermore, in many cases the
complexity of ligand−receptor binding interactions cannot be
fully recapitulated with short peptides. The ability to attach
larger peptides and proteins to the self-assembled PA
nanostructure would therefore expand the scope of possible
biological applications.
One approach for conjugating larger peptides and proteins to
the self-assembled PA nanostructure is native chemical ligation
(NCL). Originally developed by Dawson et al. in 1994, NCL
achieves the chemoselective formation of a native peptide bond
between peptides or protein fragments.19 This reaction occurs
at neutral pH upon simple mixing of two reactive precursors,
one containing an N-terminal cysteine residue and the other
containing a C-terminal thioester moiety.20 In contrast with
conjugation strategies such as carbodiimide-mediated amide
chemistry or Schiﬀ base formation, amine-containing lysine
residues and carboxylic acid-containing glutamate and aspartate
residues do not interfere with the NCL reaction. Moreover, the
NCL reaction occurs under biocompatible conditions, unlike
other chemoselective conjugation strategies such as copper-
catalyzed click chemistry.21 In the context of peptide-based self-
assembled systems, the NCL reaction has been utilized to
enhance the mechanical strength of a hydrogel composed of
ﬁbrillar β-sheet peptides via terminal cross-linking22 and for
surface PEGylation of self-assembled monolayers.23 The
biocompatibility of the NCL reaction has been demonstrated
by its use in a FRET-based probe for in vivo cellular imaging24
and by its use for cross-linking soluble polymers into hydrogels
for three-dimensional cell culture.25 In addition, the NCL
reaction has been used to conjugate relatively large bioactive
moieties, including proteins and other macromolecules.26
In this work, we investigate the use of post-assembly
modiﬁcation of PA nanostructures using NCL as an approach
to add bioactivity while retaining the basic one-dimensional
morphology. As a model, our objective has been to carry out
functionalization of ﬁbers with the ﬁbronectin derived epitope
RGDS27 as a bioactive cue. We have also investigated the
attachment of proteins to the ﬁbers using thioester-terminated
ﬂuorescent proteins.
■ RESULTS AND DISCUSSION
NCL Conjugation of RGDS Peptide to the Surface of
PA Nanoﬁbers. The NCL reaction was used to conjugate
peptides functionalized with an N-acyl-benzimidazolinone
leaving group at the carboxy terminus20 (peptide-Nbz, 2) to
PA molecules functionalized with a cysteine residue at the
amino terminus (CysPA, 1). Both components were synthe-
sized using standard Fmoc-protected solid phase peptide
synthesis with commercially available resins. The NCL reaction
was performed upon simple mixing of reactants in the presence
of a mild reducing agent (DTT) and thiol catalyst (4-MPAA)
in PBS at pH 7.4 (Figure 1). This reaction occurs via a three-
step mechanism,19a with initial substitution of the peptide-Nbz
leaving group with the thiol catalyst to form a thioester,
followed by attack from the free thiol group of the cysteine on
the CysPA, and ﬁnally an irreversible intramolecular rearrange-
ment that generates the native peptide bond (SI Figure 1a).
Figure 1. NCL reaction scheme. The reaction mixture containing 1 mM CysPA (1), 1 mM peptide-Nbz (2), 5 mM 4-MPAA, and 5 mM DTT in
PBS was reacted at pH 7.4 for 24 h at 37 °C to generate peptide-functionalized PA (3). The peptides used in the reaction are RGDS (2a,3a), biotin-
RGDS (2b,3b), and RGES (2c,3c).
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This mechanism was conﬁrmed by observing the presence of
the thioester intermediate 4 in the mass spectrum of the NCL
reaction at 3 h (SI Figure 1b).
The solution-phase NCL reaction was analyzed by liquid
chromatography with electrospray ionization mass spectrome-
try (LC-MS). A 1:1 mixture of the two reactants generated the
desired product (RGDS-PA, 3a) that was separable from the
CysPA (Figure 2a). Two major peaks identiﬁed in the mass
spectra were the CysPA 1 and the RGDS-PA product 3a
(Figure 2b,c). Based on integration of the major peaks, the
NCL reaction proceeded to 46% conversion of the CysPA.
Similar analyses on NCL reactions with diﬀerent reagent
mixtures are shown in Figure 2d. Increasing the concentration
of the RGDS-Nbz to a 5-fold excess increased the conversion to
68%. We hypothesize that the proximity of the reactive cysteine
residues on the surface of the CysPA nanoﬁbers creates steric
limitations preventing the reaction from achieving quantitative
conversion of all reactive sites. However, complete conversion
of reactive sites is not necessary to achieve optimal bioactivity,
as we demonstrate below.
The self-assembled nanostructures that the CysPA formed
were analyzed before and after the NCL reaction using
negatively stained transmission electron microscopy (TEM).
The CysPA self-assembled in aqueous solution into high aspect
ratio nanoﬁbers of approximately 10 nm diameters with a
variable degree of bundling, and this morphology was
conserved following the NCL reaction (Figure 3a and b).
The secondary structure within the nanoﬁbers was investigated
using CD spectroscopy (SI Figure 2). The CD spectra of the
CysPA before and after the NCL reaction with RGDS-Nbz
peptide suggested a mixture of β-sheet and random coil
secondary structure (estimated by ﬁtting to linear combinations
of reference spectra) with a minimal change caused by the
conjugation of epitope. Interestingly, the spectra from
presynthesized RGDS-PA had a predominant α-helical
character. This result indicates that the presence of epitope
on the PA molecule could inﬂuence the self-assembly process
and the resulting secondary structure.
To conﬁrm that the ligated peptide is present on the surface
of the PA nanoﬁber, we added a biotin group to the N-terminus
of the RGDS-Nbz peptide (biotin-RGDS-Nbz, 2b) and used
NCL to attach this peptide to the CysPA nanoﬁber. Labeling
the reaction product (biotin-RGDS-PA, 3b) with 10 nm
streptavidin-conjugated gold nanoparticles (SA-gold) con-
ﬁrmed the ligation and accessibility of biotin-RGDS peptide
on the nanoﬁber surface (Figure 3d). The SA-gold did not bind
to CysPA nanoﬁbers reacted with nonbiotinylated RGDS
peptide (Figure 3c). This result also demonstrates another
potential strategy for incorporation of bioactivity, as the
accessible biotin moiety can be utilized for further functional-
ization of the PA surface with avidin-conjugated bioactive
molecules.
Cellular Response to RGDS-Ligated Nanoﬁbers. The
binding of SA-gold to biotin-RGDS-conjugated nanoﬁbers
conﬁrmed the accessibility of the NCL-conjugated peptides on
the nanoﬁber surface. We next investigated whether such post-
assembly peptide conjugation could be used to deliver ECM
signals to cells. Since ﬁbroblasts are extensively studied in the
context of RGDS presenting scaﬀold materials,15,28 we used
these cells to test the bioactivity of NCL-modiﬁed PA
Figure 2. Reaction yields and analysis. (a) LCMS trace of NCL reaction between RGDS peptide and CysPA. (b,c) The two major peaks correspond
to the RGDS-PA product 3a (b) and residual CysPA 1 (c). (d) The percent conversion of the CysPA was calculated based on integration of the
peaks for multiple NCL reactions.
Figure 3. Surface accessibility of NCL-conjugated PA assemblies. (a,b)
TEM micrograph of CysPA (a) and NCL RGDS-PA (b) negatively
stained with uranyl acetate. (c,d) TEM micrographs of NCL RGDS-
PA (c) and NCL biotin-RGDS-PA (d) following incubation with
streptavidin-conjugated gold nanoparticles (SA-gold).
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nanoﬁbers. Cell response was measured to PAs coated on glass
coverslips using a method previously established in our group.29
Sterile coverslips were ﬁrst coated with cationic poly(D-lysine)
(PDL) and subsequently with a layer of anionic alginate, and
ﬁnally with the cationic PA nanoﬁbers (SI Figure 3). Not only
does this method of sequential coating help to achieve a
uniform PA layer on the surface, but the intermediate
nonfouling alginate layer also prevents any confounding cell
response resulting from attachment to underlying glass or PDL.
NIH/3T3 mouse embryonic ﬁbroblasts were seeded on these
PA-coated surfaces and maintained under serum-free con-
ditions to minimize nonspeciﬁc adsorption of proteins to the
nanoﬁbers.30
Fibroblast morphology was evaluated after 5 h of culture, as
such short incubation was found to be suitable by our group
and others for comparison of their response to sub-
strates.28,29,31 Fibroblasts were found to attach to CysPA
surfaces but displayed a rounded morphology indicating a lack
of cell spreading and adhesion (Figure 4a). This observation
can be explained by the ability of PA nanoﬁbers to provide cell
attachment; however, an absence of an integrin-binding cue
limits their spreading. In contrast, on the CysPA surfaces
functionalized with the RGDS peptide using the NCL reaction
(NCL RGDS-PA), cells appeared to be more spread with the
presence of prominent cytoplasmic processes giving the cells a
stellate morphology, similar to that found on presynthesized
RGDS-PA (Figure 4c,e). The observed change in cell
morphology was further quantiﬁed by measurement of
circularity, calculated as 4π × area/perimeter so that a perfectly
round cell will have a value of 1.32 The circularity of ﬁbroblasts
on the NCL RGDS-PA surface was 0.38 ± 0.03, signiﬁcantly
lower than the value of 0.65 ± 0.04 found on the CysPA surface
(Figure 4f). Cell viability was found to be higher than 95% in
each of these conditions (SI Figure 4), indicating that a toxic
response to the underlying substrate is not attributable to the
diﬀerence in the cell morphology. To further evaluate whether
the observed change in the cell morphology was speciﬁc to the
RGDS sequence, we conjugated a mutated non-bioactive RGES
peptide to CysPA nanoﬁbers using the NCL reaction (NCL
RGES-PA). Fibroblasts on the NCL RGES-PA surface (Figure
4d) had a circularity of 0.56 ± 0.04, which was not signiﬁcantly
diﬀerent from the circularity on the CysPA surface, indicating
that the change in cell morphology is due to the speciﬁc
bioactivity of the RGDS peptide and not due to the conditions
of the NCL reaction. Furthermore, addition of soluble RGDS
peptide into the culture medium did not alter the morphology
of cells on the CysPA surface (Figure 4b), conﬁrming the need
for tethering of the RGDS peptide to nanoﬁbers to provide for
cell signaling.
Although NCL did not achieve full conjugation eﬃciency,
several reports from our group and others have shown that the
presence of 10% bioactive molecules in a peptide nanoﬁber
system is suﬃcient to demonstrate the maximal cell
response.15,22 Consistent with those ﬁndings, we observed a
comparable cell response between the NCL RGDS-PA surfaces
and the presynthesized RGDS-PA surfaces, which have a cue
present on every molecule. It has been suggested that the
critical RGD sequence density required for ﬁbroblast spreading
is determined by the steric factor separating two integrin
molecules.33 Even with a submaximal functionalization,
following NCL reaction, RGDS sequence availability on the
nanoﬁber surface would be suﬃcient for maximal integrin
binding.
Figure 4. Fibroblast morphology on PA-coated coverslips. (a−e) Fluorescent micrographs of NIH/3T3 ﬁbroblasts cultured for 5 h and stained by
phalloidin for F-actin on coverslips coated with CysPA (a), CysPA and soluble RGDS peptide (b), NCL RGDS-PA (c), NCL RGES-PA (d), and
presynthesized RGDS-PA not formed by NCL (e). (f) Comparison of cell circularity (4π × area/perimeter2) on various PA-coated surfaces (** p <
0.01 vs CysPA, n = 100 cells).
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Apart from the possibility of post-assembly functionalization
of PA nanoﬁbers, the NCL conjugation strategy allows
simultaneous covalent functionalization of the PA nanoﬁber
with multiple diﬀerent bioactive ligands. This approach could
take advantage of potential synergies among diﬀerent classes of
bioactive ligands without the need for independent chemical
conjugation schemes for each component. Furthermore, the
relative biocompatibility of the NCL reaction mixture creates
the opportunity for temporal control over ligand conjugation in
live cell culture, potentially allowing the sequentially timed
presentation of bioactive cues to inﬂuence cell behaviors such
as diﬀerentiation.
Protein Ligation to PA Nanoﬁbers in Solution and on
Coated Surfaces. Next, we sought to extend the scope of the
NCL method for biofunctionalization of PA nanoﬁbers to
larger molecules such as proteins. To demonstrate that the
NCL reaction can be used to ligate proteins to the PA
nanoﬁber, we utilized YFP that was expressed with a self-
cleavable intein domain and puriﬁed with 2-mercaptoethane
sulfonate sodium salt (MESNA) to yield a thioester at the C-
terminus. This YFP-MESNA was ligated to the CysPA via NCL
with dilute reactant concentrations (Figure 5a). The overall
nanoﬁber morphology of the CysPA was retained following
conjugation with YFP, although the nanoﬁbers appear wider
Figure 5. Protein ligation to PA nanostructures via NCL. (a) Schematic of NCL conjugation of YFP to CysPA using YFP-MESNA. (b,c) TEM
micrograph of CysPA assemblies prior to (b) and following NCL with YFP (c). (d) Emission spectra of YFP following NCL conjugation to CysPA
coassembled with diﬀerent concentrations of TAMRA-labeled PA.
Figure 6. Characterization of PA−protein conjugates formed by NCL. (a,b) SDS-PAGE visualized by silver staining (a) and Western blot against
GFP (b) were used to analyze the NCL reaction between YFP and PA (Lane 1: YFP only, Lane 2: YFP conjugated to CysPA, Lane 3: CysPA only,
Lanes L1, L2, L3: protein standards with indicated molecular weights in kDa). (c) YFP ﬂuorescence intensity after conjugation to CysPA-coated
surface (CysPA-YFP NCL). An identical PA lacking cysteine (GlyPA-YFP Control) or CysPA treated with reaction buﬀer alone (CysPA Control)
was used as a control (** p < 0.01 vs CysPA-YFP NCL). (d) Confocal ﬂuorescence microscopy of CysPA nanoﬁber-coated alginate microparticles
simultaneously reacted with YFP and CFP. (e) Fluorescence anisotropy of YFP following NCL reaction with CysPA. GlyPA was used as a control (*
p < 0.05 vs YFP; # p < 0.05 vs GlyPA).
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and less bundled (Figure 5b,c). These changes would be
expected upon ligation of large proteins onto the nanoﬁber
surface.
The CysPA-YFP NCL reaction mixture was analyzed by
SDS-PAGE to identify the reaction product. Two distinct bands
were detected on silver staining, one corresponding to the YFP
and a second for a product that appears to have higher
electrophoretic mobility than the YFP (Figure 6a). Western
blot analysis showed both bands to be positively stained with
anti-GFP antibody (Figure 6b). We attribute the band with
higher electrophoretic mobility to YFP conjugated with PA;
although conventionally, the electrophoretic mobility would be
expected to decrease following conjugation due to an increase
in molecular mass, we believe the character of the PA molecule
to be responsible for the increased electrophoretic mobility.
The conjugation of the PA molecule adds a highly hydrophobic
aliphatic chain and three positively charged lysine residues to
the YFP protein, and due to this aliphatic chain and these
positive charges, the PA molecule can potentially bind a higher
number of SDS molecules relative to its molecular mass than
the protein alone, resulting in an increase in surface charge that
is disproportionately higher than the increase in mass. This “gel
shifting” eﬀect has been observed for other proteins modiﬁed
with hydrophobic groups,34 as well as other peptide amphiphile
systems35 analyzed by electrophoresis with SDS. This eﬀect
would increase the apparent electrophoretic mobility of the
product on SDS-PAGE, consistent with the new band observed
in the reaction mixture. The possibility of the second band
being a YFP degradation product can be excluded because the
YFP control was treated under exactly the same conditions as
the NCL reaction except for the absence of PA. Taken together,
the new band observed in the reaction mixture likely
corresponds to the CysPA-YFP ligation product.
In order to conﬁrm the YFP immobilization on the CysPA
nanoﬁbers, we performed FRET experiments. The CysPA was
coassembled with TAMRA-labeled PA (SI Figure 3a), which
has an excitation spectrum that overlaps the YFP emission
spectrum, forming a FRET pair. The proximity of YFP to
TAMRA ﬂuorophores on the nanoﬁber surface should
therefore induce FRET and quench the YFP emission. For
distances in the range of the Förster radius, closer proximity of
the ﬂuorophores will induce a greater degree of YFP emission
quenching. This eﬀect was observed as shown in Figure 5d,
where all spectra were normalized using the maximum intensity
observed in the absence of TAMRA (YFP emission maximum
at 525 nm). Increasing the molar concentration of the
TAMRA-labeled PA increases the surface density of acceptors.
A higher density of TAMRA on the nanoﬁber surface eﬀectively
reduces the average distance from YFP attached via NCL,
resulting in greater quenching. In fact, increasing the
proportion of TAMRA-labeled PA from 1 to 2 mol %
generated an increase in the quenching of YFP ﬂuorescence
from 20% to 80%. For single donor−acceptor FRET pairs, the
decrease in intensity of the donor is accompanied by an
increase in intensity of the acceptor. However, at 2 mol %
TAMRA ﬂuorophore density on the nanoﬁber surface was high
enough to induce self-quenching due to homo-FRET
phenomena. Consequently, we did not observe an increased
intensity of TAMRA signal with increasing energy transfer
between YFP and TAMRA-PA.
The speciﬁcity of YFP immobilization on CysPA nanoﬁbers
via NCL was further conﬁrmed by ﬂuorescence anisotropy (r)
measurements. In the absence of depolarization phenomena,
such as homo-FRET, light scattering, or reabsorption, the
anisotropy only depends on the rotational diﬀusion of the
ﬂuorophore. If the rotational diﬀusion rate of a ﬂuorophore is
of similar magnitude to the ﬂuorescence decay rate, the slower
rotational diﬀusion rate expected upon binding will be reﬂected
as an increase in anisotropy. As shown in Figure 6e, at less than
10 nM, YFP anisotropy increased after NCL with CysPA but
remained essentially the same in the presence of an identical PA
lacking the N-terminal cysteine (GlyPA). Interestingly, the
anisotropy decreased steadily as the concentration increased
above a threshold of 10 nM YFP. At higher concentration of
YFP, the likelihood for the distance between two or more YFP
molecules to be shorter than the Förster radius for homo-FRET
can no longer be neglected. Therefore, the anisotropy decreases
due to energy transfer between ﬂuorophores with diﬀerent
orientations. A similar behavior was observed previously for
YFP-labeled protein homodimers and used to detect protein
reorientation upon binding.36 These results provide evidence
not only that the YFP was immobilized on the CysPA
nanoﬁbers by NCL, but also that the surface density of
immobilized YFP increased as the YFP to CysPA molar ratio
increased in the reaction mixture.
Finally, we sought to demonstrate that protein ligation via
NCL can be achieved on PA nanoﬁber-coated surfaces. Higher
ﬂuorescence intensity was observed following the NCL-
mediated conjugation of YFP to CysPA nanoﬁbers coated on
glass coverslips (Figure 6c). Conversely, adding the same YFP-
containing reaction mixture to an identical PA lacking the N-
terminal cysteine (GlyPA) produced signiﬁcantly lower
ﬂuorescence intensity, indicating that the observed ﬂuorescence
was due to retention of the YFP by a speciﬁc reaction with
CysPA and not a nonspeciﬁc adsorption to PA nanoﬁbers. To
demonstrate a potential application of protein ligation to PA
nanoﬁber-coated surfaces via NCL, we utilized cell-size alginate
microparticles electrostatically conjugated with a coating of
CysPA nanoﬁbers by a process similar to the formation of the
CysPA-coated glass coverslips. We simultaneously ligated YFP
and cyan ﬂuorescent protein (CFP) to the surfaces of these
CysPA-coated microparticles and visualized their surface
ﬂuorescence by confocal microscopy. The surfaces of the
microparticles showed colocalized YFP and CFP ﬂuorescence
(Figure 5d), indicating that the two proteins were coligated to
the PA-coated microparticles. A full view of the ﬁeld shows
separate areas of high intensity for each ﬂuorophore, indicating
that colocalization of ﬂuorescence was not due to spectral
bleed-through (SI Figure 3d).
The approach of conjugating proteins to PA nanoﬁbers by
NCL as described here can be applied to any protein expressed
with a C-terminal intein domain and puriﬁed by thiol-mediated
cleavage. The conjugated protein can potentially fulﬁll multiple
functions, including targeting, adhesion, and cell signaling.
These functions are especially useful when combined with the
advantages oﬀered by PA nanoﬁbers, including the ability to
encapsulate hydrophobic drugs, form a scaﬀold that mimics
ECM, and coat polymer surfaces. For example, PA nanoﬁbers
encapsulating therapeutic agents37 or drug loaded alginate
particles coated with PA nanoﬁbers could be targeted to speciﬁc
cells and tissues via proteins conjugated by NCL. The
conjugation of proteins to PA nanoﬁbers via NCL would
facilitate these potential applications while maintaining the
desirable properties of biodegradability and biocompatibility
inherent to the PA molecule.
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■ CONCLUSIONS
We have demonstrated here the use of native chemical ligation
to conjugate both bioactive peptides and ﬂuorescent proteins to
self-assembled peptide amphiphile nanoﬁbers. The ligated
peptides and proteins were displayed on the nanoﬁber surface
without compromising the morphology of the supramolecular
nanostructures. Evidence for bioactivity was established by the
observation of ﬁbroblast spreading following conjugation of a
biological signal to nanoﬁbers using the ligation reaction. Our
results suggest that post-assembly chemical ligation could be a
useful tool to tailor the bioactivity of supramolecular
nanostructures.
■ EXPERIMENTAL PROCEDURES
Peptide Synthesis and Puriﬁcation. All PAs and peptides
were synthesized by ﬂuorenylmethoxycarbonyl (Fmoc) pro-
tected solid-phase peptide synthesis as previously reported by
our group7a using materials purchased from EMD Chemicals
Inc. (Merck KGaA, Darmstadt, Germany) unless otherwise
indicated. Brieﬂy, the PAs were synthesized at 0.25 mmol scale
on Rink Amide MBHA resin, and peptides functionalized at the
carboxy-terminus with an N-acyl-benzimidazolinone for native
chemical ligation (peptide-Nbz) were synthesized at 0.25 mmol
scale on 3-(Fmoc-amino)-4-aminobenzoyl AM resin. For each
amino acid addition, the resin was deprotected using 2% 1,8-
diazabicycloundec-7-ene (DBU) and 2% piperidine in N,N-
dimethylformamide (DMF), and the amino acid was coupled
using 4 equiv of protected amino acid functionalized with 4
equiv of 2-(1h-benzotriazole-1-yl)-1,1,3,3- tetramethyluronium
hexaﬂuorophosphate (HBTU) and 6 equiv of N,N-diisopropy-
lethylamine (DIPEA) in DMF. The dodecanoic acid tail was
similarly functionalized and coupled to a lysine side chain
following selective deprotection of the 4-methyltrityl (Mtt)
group using a 92:5:3 mixture of dichloromethane (DCM),
triisopropylsilane (TIPS), and triﬂuoroacetic acid (TFA). For
synthesis of peptide-Nbz, a Boc-protected amino acid was
added at the N-terminus, and the resin was treated with 5 equiv
p-nitrophenylchloroformate in DCM followed by 0.5 M DIPEA
in DMF for activation. Resin cleavage and amino acid
deprotection was performed using a 95:2.5:2.5 mixture of
TFA, TIPS, and water for all PAs and peptides. Following
removal of solvent by rotary evaporation, the crude PAs/
peptides were precipitated by addition of cold diethyl ether.
The precipitate was collected and dried in vacuo to generate
crude product with identity conﬁrmed by electrospray
ionization (ESI) mass spectrometry. All PAs and peptides
were puriﬁed by reverse-phase high performance liquid
chromatography (HPLC) as previously reported by our
group.7a Brieﬂy, the crude product was dissolved in 0.1%
TFA in water, ﬁltered, injected onto a Gemini-NX 5 μm C18
column, and eluted using a water-acetonitrile solvent gradient
for separation. The puriﬁed product was lyophilized and stored
at −20 °C. To conjugate biotin, 10 mM RGDS-Nbz peptide in
PBS was mixed 1:1 with 20 mM sulfo-NHS-biotin (Thermo
Scientiﬁc, Rockford, IL) in PBS and reacted for 4 h at room
temperature and overnight at 4 °C. The biotinylated peptide
was puriﬁed from the reaction mixture by HPLC, lyophilized,
and stored at −20 °C.
Protein Expression and Puriﬁcation. The pTXB1-EYFP
and pTXB1-ECFP plasmids (see Supporting Information) were
transformed, according to the manufacturer’s protocol, into E.
coli BL21 (DE3) (Novagen) competent cells by electro-
poration.38 The transformed cells were plated on Lysogeny
Broth (LB)-agar plates containing ampicillin (Amp) and grown
overnight at 37 °C. Single colonies were picked and grown in
30 mL LB medium (10 g peptone, 5 g yeast extract, 10 g
sodium chloride, 1 L water) containing Amp overnight at 37 °C
in shaker at 250 rpm. Cells were stored in 1 mL aliquots at −80
°C in the presence of 15% (w/v) glycerol. For overnight
cultures, 10 mL of Amp-containing LB was inoculated with ∼1
μL of the glycerol stock and grown overnight at 37 °C and 250
rpm. For small-scale expression, volumes of 30 mL were used,
while large-scale expression was performed in 500 mL LB
medium. Cell culturing was started with 5 mL overnight culture
and cells were grown at 37 °C, 250 rpm in the presence of
Amp. When an optical density (OD600) of 0.6−0.8 was reached,
protein expression was induced by the addition of isopropyl-β-
D-thiogalatopyranoside (IPTG; Duchefa Biochemie). Large-
scale expression was induced by 0.5 mM IPTG and grown
overnight at 15 °C. Cell harvesting was performed by
centrifuging the cell culture for 5 min at 10,000 g at 4 °C.
The supernatant was removed and the cell pellet was
resuspended in 5 mL Bugbuster (Novagen) and 5 μL
benzonase (Novagen) per gram of cell pellet. After incubation
for 20 min at 21 °C, the cell suspension was centrifuged at
16,000 g for 20 min at 4 °C. The supernatant was directly
applied to 10 mL chitin beads (New England Biolabs),
equilibrated with 10 column volumes of column buﬀer (20
mM sodium phosphate, 0.5 M sodium chloride, pH 6). The
loaded column was washed with 10 volumes of column buﬀer
after which the column was quickly ﬂushed with 2 column
volumes of cleavage buﬀer (20 mM sodium phosphate, 0.5 M
sodium chloride, 100 mM 2-mercaptoethane sulfonic acid
(MESNA), pH 6). Subsequently, the ﬂow was stopped and the
column with the cleavage buﬀer was incubated 2 × 20 h at
room temperature (using fresh cleavage buﬀer for the second
time). Elution fractions containing the cleaved proteins with a
C-terminal thioester were collected and pooled. The proteins
were buﬀer-exchanged (into 20 mM Tris, 150 mM sodium
chloride, pH 7.8) using Amicon ultra centrifuge tubes
(MWCO: 10 kDa), after which the concentration was
measured using UV−vis. Protein solutions were stored at
−80 °C.
Native Chemical Ligation Reaction in Solution. The N-
terminal cysteine PA (CysPA) was mixed with 5 equiv of
dithiothreitol (DTT) and dissolved in phosphate-buﬀered
saline (PBS) at pH 7.4, and the peptide-Nbz or YFP-MESNA
was mixed with 5 equiv of 4-mercaptophenylacetic acid (4-
MPAA) and dissolved in PBS at pH 7.4. The two reagents were
mixed at the desired ratio, and the reaction was subsequently
analyzed by liquid chromatography mass spectrometry, gel
electrophoresis, transmission electron microscopy, circular
dichroism (CD) spectroscopy, Förster resonance energy
transfer (FRET), or ﬂuorescence anisotropy as indicated.
Liquid Chromatography Mass Spectroscopy. Analytical
liquid chromatography mass spectroscopy (LC-MS) was
performed using an Agilent 1200 system with an Agilent
6250 quadrupole-time-of-ﬂight mass spectrometer using a
Phenomenex Gemini C18 column (5 μm particle size, 150 ×
1.0 mm) eluting with a gradient of 5% ACN to 95% ACN in
water, with each solvent containing 0.1% TFA. UV absorbance
was monitored at 220 nm.
Transmission Electron Microscopy. The nanostructure
morphology of each PA was characterized using conventional
transmission electron microscopy (TEM). Each PA or NCL
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reaction mixture was diluted in water to 0.1 mM PA, and 7.5 μL
of this solution was deposited on a copper grid with 300 mesh
carbon support ﬁlm for 5 min, washed with water twice for 1
min each, negatively stained with 2% (w/v) uranyl acetate twice
for 30 s each, and dried at room temperature overnight.
For labeling, streptavidin-conjugated 10 nm gold nano-
particles in suspension (Sigma-Aldrich, St. Louis, MO) were
mixed at 1:1 volume ratio with 20 mM dithiothreitol (DTT) in
PBS and incubated for 30 min to prevent nonspeciﬁc thiol
binding to the gold. This suspension was mixed at a 1:4 volume
ratio with the PA or NCL reaction mixture and incubated for
30 min to allow streptavidin binding to biotin. This mixture was
diluted to 0.1 mM PA and deposited onto the copper grid as
described above, except with four water washes to ensure
complete removal of unbound gold nanoparticles. All images
were acquired using an FEI Tecnai Spirit G2 microscope
working at 120 kV.
Circular Dichroism Spectroscopy. Circular dichroism
(CD) spectra of PA (1 mM) in PBS or NCL reaction mixture
were acquired on a JASCO J-715 CD spectrophotometer at
room temperature using quartz plates with a 0.05 mm path
length. The CD spectra were ﬁt to linear combinations of
reference spectra for known secondary structures using the
PEPFIT algorithm39 to estimate secondary structure.
Gel Electrophoresis and Western Blotting. Polyacryla-
mide gel electrophoresis with sodium dodecyl sulfate (SDS-
PAGE) was performed using 17.5% polyacrylamide gels.
Samples were prepared in SDS sample buﬀer with 4 M urea
and heated for 5 min at 95 °C. The reaction mixture and
controls were diluted 15-fold resulting in consistent protein
loadings of approximately 5.6 μg per well for the YFP and 0.5
μg per well for the CysPA across all samples. As reference, Bio-
Rad Precision Plus Unstained Protein Standard was used for
both silver stain and Western blot, while Bio-Rad Broad-Range
15% Protein Standard was used speciﬁcally for the silver stain
and Magic Mark XP Western Protein Standard (Invitrogen)
was used speciﬁcally for the Western blot. Electrophoresis was
performed at 65 V for 21 h in Tris-Glycine running buﬀer using
the Pharmacia EPS 600 power supply. Gels were rinsed with
water and developed by either silver nitrate exposure or
Western blot. For the Western blot, the protein was transferred
to an immobilin-P membrane using a Bio-Rad Trans-Blot cell
with model 200/2.0 power supply at 35 V for 2 h in Tris-
Glycine transfer buﬀer. The membrane was blocked using 5%
milk in PBS + 0.3% Tween for 1 h. The membrane was then
stained with anti-GFP rabbit polyclonal primary antibody
(ab290, Abcam) at 1:5000 dilution for 1 h, washed with PBS +
0.3% Tween, further stained with goat anti-rabbit polyclonal
secondary antibody conjugated to FITC (Jackson ImmunoR-
esearch) at 1:5000 dilution for 1 h, and washed again with PBS
+ 0.3% Tween. The membrane was then read on a Fujiﬁlm
FLA-5100 imager.
Förster Resonance Energy Transfer and Fluorescence
Anisotropy. CysPA was mixed in hexaﬂuoroisopropanol
(HFIP) with 5-carboxytetramethylrhodamine (TAMRA) la-
beled PA at diﬀerent ratios (0, 1, and 2 mol %) and lyophilized
to ensure homogeneous mixing of coassembled nanoﬁbers. The
lyophilized powder was redissolved in 10 mM DTT aqueous
solution, diluted in PBS at pH 7.4, and subsequently mixed with
YFP-MESNA solution (supplemented with 5 equiv 4-MPAA),
to yield ﬁnal concentrations of YFP and PA of 1 and 100 μM,
respectively. This mixture was reacted for around 24 h before
measurements. TAMRA was used as a FRET acceptor for YFP.
The same procedure was used to prepare solutions of an
identical PA lacking the N-terminal cysteine (GlyPA). These
solutions were used as control to rule out the contribution to
FRET signal of potential nonspeciﬁc adsorption of YFP to PA
nanoﬁbers. Emission intensity spectra were recorded on a
Horiba Nanolog ﬂuorimeter, using an excitation wavelength of
485 nm (bandpass of 2 nm). Emission intensity was scanned
between 495 and 680 nm (increment of 1 nm), encompassing
both YFP and TAMRA emission ranges, using a bandpass of 2
nm, integration time of 0.1 s, and PMT detector set at 950 kV.
A similar procedure was used to prepare solutions for
ﬂuorescence anisotropy (FA), but without TAMRA labeled
PA, and at variable YFP concentration (1−500 nM). FA was
recorded at an emission wavelength of 535 nm (excitation at
495 nm), 1 s integration time, and using variable mono-
chromators’ bandpasses, which were set to guarantee signal
intensities over 10 kCPS. Intensity was recorded at the four
possible combinations for the orientations of excitation and
emission polarizers: both along the vertical direction (IVV), both
oriented horizontally (IHH), the excitation polarizer oriented
vertically and the emission horizontally (IVH), or vice versa
(IHV). FA (r) was calculated according to the following
equation:
= − +r I I I I I I I I( . . )/( . 2 . )VV HH VH HV VV HH VH HV
The correct alignment of the polarizers was veriﬁed using a
diluted colloidal silica suspension (r ≥ 0.97).
Native Chemical Ligation Reaction on PA-Coated
Surfaces and Microparticles. All PAs, peptides, and other
materials were UV-sterilized prior to use to maintain sterility.
12 mm glass coverslips were coated with 0.01% poly(D-lysine)
(PDL) overnight and then washed with water and dried
overnight. The PDL-coated coverslips were then coated with
0.25% alginate dissolved in water for 1 h, after which the
alginate was cross-linked with 10 mM calcium chloride in water.
The alginate-coated coverslips were then coated with 0.5 mM
PA dissolved in water with 5 equiv DTT overnight. Alginate
microparticles were similarly coated with 0.5 mM PA dissolved
in water with 5 equiv DTT for 30 min. Following wash steps
with water and PBS, the PA-coated coverslips or microparticles
were immersed in NCL solution, which contained either 0.5
mM peptide-Nbz or 5 μM YFP-MESNA and 5 μM CFP-
MESNA dissolved in PBS with 5 equiv of 4-MPAA and DTT.
Following a 24 h incubation at 37 °C, the coverslips or
microparticles were washed with PBS, and the coverslips were
either used for cell morphology and viability studies or assayed
for YFP ﬂuorescence on a SpectraMax M5 microplate reader,
while the microparticles were visualized by confocal microscopy
for both YFP and CFP ﬂuorescence.
Cell Culture. NIH/3T3 mouse embryonic ﬁbroblasts
(American Type Culture Collection, Manassas, VA) were
maintained in monolayer culture in T25 culture ﬂasks. Growth
medium consisted of Dulbecco’s Modiﬁed Eagle Medium
(DMEM) with high glucose supplemented with 10% fetal
bovine serum, 100 U/mL penicillin, and 100 μg/mL
streptomycin. Assay medium consisted of growth medium
without serum.
Cell Morphology and Viability Assays. The PA-coated
coverslips functionalized using the NCL reaction were placed in
24-well plates and seeded with 5,000 NIH/3T3 ﬁbroblasts in 1
mL assay medium per well. Following a 5 h incubation at 5%
CO2 and 37 °C, the coverslips were washed with PBS
containing 1 mM CaCl2 and ﬁxed for subsequent analysis.
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For quantiﬁcation of cell spreading, ﬁbroblasts were stained
with phalloidin and visualized by light microscopy. Coverslips
were ﬁxed in 4% paraformaldehyde in PBS for 30 min at room
temperature, then blocked with blocking buﬀer (10% normal
goat serum, 2% bovine serum albumin, and 0.4% Triton X100)
for 30 min at 4 °C, then stained for F-actin with rhodamine-
phalloidin (Invitrogen, Grand Island, NY) at 1:500 dilution for
2 h at room temperature, and ﬁnally dried and mounted on
slides for light microscopy. Solutions used in ﬁxing, staining,
and washing steps were supplemented with 1 mM CaCl2 to
maintain alginate cross-linking. The cells were imaged using a
Nikon Eclipse TE2000-U inverted ﬂuorescence microscope,
and images were analyzed using the Shape Descriptor 1u plugin
on ImageJ software (NIH) to determine the circularity of the
cells (calculated as 4π × area/perimeter2).
Cell viability was assessed using commercially available
LIVE/DEAD cell viability assay kit (Life Technologies).
Fibroblasts were cultured on PA coating for 5 h and stained
with 1 μg/mL calcein AM and 1 μg/mL ethidium homodimer-
1 following manufacturer’s protocol. Live cell (calcein positive)
and dead cell (ethidium homodimer positive) populations were
counted manually under an inverted ﬂuorescence microscope
(Nikon Eclipse TE2000-U).
Statistics and Data Analysis. For the determination of
form factor, ﬁve images from each of two replicates of each
condition were analyzed, and the mean and standard deviation
of the form factor of cells were calculated across all ten images.
To establish statistical signiﬁcance, each condition was
compared to CysPA alone using the Student’s t test. For
comparison of cell viability approximately 100 cells were
counted from at least two replicates per condition. The cell
viability index was deﬁned as the ratio of calcein positive cells to
the total number of cells. Statistical signiﬁcance was measured
against CysPA alone. For the determination of YFP
ﬂuorescence on PA coatings, two independent measurements
of the ﬂuorescence emission at 535 nm following excitation at
495 nm were taken from each of four replicates of each
condition, and the mean and standard error were calculated
based on these four replicates for each condition following
background subtraction of wells with alginate-coated coverslips
without PA nanoﬁbers. To establish statistical signiﬁcance, the
CysPA-YFP NCL condition was compared to each control
using the Student’s t test. For the statistical comparison of
ﬂuorescence anisotropy, three independent replicates were
measured for each condition, and the CysPA condition was
compared to the GlyPA and YFP only conditions using the
Student’s t test.
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